• All
  • Follow Up
  • Pharmacodynamics
  • Pharmacokinetics
  • Immunology / Risk Assesment

Recommendation for Selecting Tests

  • Oncocount R.G.C.C. or
  • Oncotrace R.G.C.C. or
  • Oncotrail R.G.C.C. only for known and specific types of malignancies

For the first year every trimester and then every half year

For a period of three years a Meta analysis has been conducted comparing CTCs profile and metastases profile in order to detect potent markers that are relevant with the site of relapse. Metastat tests provides this information.